Why Joe Biden’s Big Pharma patent grab is a terrible idea

The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dangers for the future.

Free, fast, fair

Continue reading this article and get instant access to even more investment news by registering your details below:

We will use the details you have shared to manage your registration. You agree to the processing, storage, sharing and use of this information for the purpose of managing your registration as described in our Privacy Policy.

We will use the details you have shared to manage your newsletter subscription. You agree to the processing, storage, sharing and use of this information for the purpose of managing your subscription as described in our Privacy Policy.

We will use the information you have shared for carefully considered and specific purposes, where we believe we have a legitimate case to do so, for example to send you communications about similar products and services we offer. You can find out more about our legitimate interest activity in our privacy policy.

‘We’ includes MoneyWeek and other Dennis Group brands as detailed here

Reset your password

A link has been emailed to you - check your inbox.



Don't have an account? Click here to register

Recommended

Stockmarkets are due a breather
Stockmarkets

Stockmarkets are due a breather

Inflation jitters look overdone, but high valuations mean equities will still tread water for a few months, says Max King
7 Jun 2021
How to invest in biotechnology: the healthcare sector’s high-growth area
Biotech stocks

How to invest in biotechnology: the healthcare sector’s high-growth area

Dr Mike Tubbs provides an overview of this thriving industry, whose latest triumphs include the Covid-19 vaccines. He examines the best investment str…
14 May 2021
Stockmarkets have a spring in their step
Stockmarkets

Stockmarkets have a spring in their step

Global stockmarkets have been basking in the post-Covid economic recovery as GDP, retail sales and manufacturing are all on the way back up.
23 Apr 2021
Three winners of the long-term biotech boom
Share tips

Three winners of the long-term biotech boom

Professional investor Marek Poszepcynski of the International Biotechnology Trust picks three biotech stocks with good pipelines, strong management te…
22 Mar 2021

Most Popular

The real problem of Universal Basic Income (UBI)
US Economy

The real problem of Universal Basic Income (UBI)

April employment numbers showed 75 per cent fewer people in the US returned to employment compared to expectations. Merryn Somerset-Webb explains how …
1 Jun 2021
The biggest threat to crypto comes from stablecoins
Bitcoin & crypto

The biggest threat to crypto comes from stablecoins

Governments are increasingly getting worried about "stablecoins", cryptocurrencies which have a more "stable value". John Stepek explains what stablec…
3 Jun 2021
Why it might be better to delay saving for your retirement
Pensions

Why it might be better to delay saving for your retirement

We are advised to put aside as much as we can as early as possible. But is that always sensible?
8 Jun 2021